The DOI matches its Crossref record; 231 of the 231 references it cites were found in a registry or an index.
Systemic delivery of peptides by the oral route: Formulation and medicinal chemistry approaches
Open accessAbstract
In its 33 years, ADDR has published regularly on the po5tential of oral delivery of biologics especially peptides and proteins. In the intervening period, analysis of the preclinical and clinical trial failures of many purported platform technologies has led to reflection on the true status of the field and reigning in of expectations. Oral formulations of semaglutide, octreotide, and salmon calcitonin have completed Phase III trials, with oral semaglutide being approved by the FDA in 2019. The progress made with oral peptide formulations based on traditional permeation enhancers is against a background of low and variable oral bioavailability values of ~1%, leading to a current perception that only potent peptides with a viable cost of synthesis can be realistically considered. Desirable features of candidates should include a large therapeutic index, some stability in the GI tract, a long elimination half-life, and a relatively low clearance rate. Administration in nanoparticle formats have largely disappointed, with few prototypes reaching clinical trials: insufficient particle loading, lack of controlled release, low epithelial particle uptake, and lack of scalable synthesis being the main reasons for discontinuation. Disruptive technologies based on engineered devices promise improvements, but scale-up and toxicology aspects are issues to address. In parallel, medicinal chemists are synthesizing stable hydrophobic macrocyclic candidate peptides of lower molecular weight and with potential for greater oral bioavailability than linear peptides, but perhaps without the same requirement for elaborate drug delivery systems. In summary, while there have been advances in understanding the limitations of peptides for oral delivery, low membrane permeability, metabolism, and high clearance rates continue to hamper progress.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Peptide therapeutics: current status and future directions
Fosgerau, K., & Hoffmann, T. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2014.10.003 · Cited by 3,030
Therapeutic peptides: Historical perspectives, current development trends, and future directions
Lau, J. L., & Dunn, M. K. (2018) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.06.052 · Cited by 1,879
Cone, R. A. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.09.008 · Cited by 1,459
Contemporary strategies for peptide macrocyclization
White, C. J., & Yudin, A. K. (2011) · Nature Chemistry · doi:10.1038/nchem.1062 · Cited by 1,088
The Discovery and Development of Liraglutide and Semaglutide
Knudsen, L. B., & Lau, J. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00155 · Cited by 970
Nonribosomal Peptide Synthesis—Principles and Prospects
Süssmuth, R. D., & Mainz, A. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201609079 · Cited by 958
Cyclic peptide therapeutics: past, present and future
Zorzi, A., Deyle, K., & Heinis, C. (2017) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2017.02.006 · Cited by 737
Non-invasive delivery strategies for biologics
Anselmo, A. C., Gokarn, Y., & Mitragotri, S. (2019) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.183 · Cited by 665
Advances in oral peptide therapeutics
Drucker, D. J. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0053-0 · Cited by 646
Pratley, R., Amod, A., Hoff, S. T., Kadowaki, T., Lingvay, I., Nauck, M., Pedersen, K. B., Saugstrup, T., & Meier, J. J. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31271-1 · Cited by 594
Understanding Cell Penetration of Cyclic Peptides
Dougherty, P. G., Sahni, A., & Pei, D. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.9b00008 · Cited by 570
Macrocyclic Drugs and Clinical Candidates: What Can Medicinal Chemists Learn from Their Properties?
Giordanetto, F., & Kihlberg, J. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm400887j · Cited by 563
Transcellular Stomach Absorption of a Derivatized Glucagon-Like Peptide-1 Receptor Agonist
Buckley, S. T., Bækdal, T. A., Vegge, A., Maarbjerg, S. J., Pyke, C., Ahnfelt-Rønne, J., Madsen, K. G., Schéele, S. G., Alanentalo, T., Kirk, R. K., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aar7047 · Cited by 553
Materials for oral delivery of proteins and peptides
Brown, T. D., Whitehead, K. A., & Mitragotri, S. (2019) · Nature Reviews Materials · doi:10.1038/s41578-019-0156-6 · Cited by 520
Prodrugs—from Serendipity to Rational Design
Huttunen, K. M., Raunio, H., & Rautio, J. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.003459 · Cited by 505
Aroda, V. R., Rosenstock, J., Terauchi, Y., Altuntas, Y., Lalic, N. M., Morales Villegas, E. C., Jeppesen, O. K., Christiansen, E., Hertz, C. L., Haluzík, M., et al. (2019) · Diabetes Care · doi:10.2337/dc19-0749 · Cited by 493
Rezai, T., Yu, B., Millhauser, G. L., Jacobson, M. P., & Lokey, R. S. (2006) · Journal of the American Chemical Society · doi:10.1021/ja0563455 · Cited by 490
Mucoadhesive nanoparticulate systems for peptide drug delivery
Takeuchi, H., Yamamoto, H., & Kawashima, Y. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00120-4 · Cited by 488
Lerner, A., & Matthias, T. (2015) · Autoimmunity Reviews · doi:10.1016/j.autrev.2015.01.009 · Cited by 475
Rodbard, H. W., Rosenstock, J., Canani, L. H., Deerochanawong, C., Gumprecht, J., Lindberg, S. Ø., Lingvay, I., Søndergaard, A. L., Treppendahl, M. B., Montanya, E., et al. (2019) · Diabetes Care · doi:10.2337/dc19-0883 · Cited by 463
An ingestible self-orienting system for oral delivery of macromolecules
Abramson, A., Caffarel-Salvador, E., Khang, M., Dellal, D., Silverstein, D., Gao, Y., Frederiksen, M. R., Vegge, A., Hubálek, F., Water, J. J., et al. (2019) · Science · doi:10.1126/science.aau2277 · Cited by 452
Orally Absorbed Cyclic Peptides
Nielsen, D. S., Shepherd, N. E., Xu, W., Lucke, A. J., Stoermer, M. J., & Fairlie, D. P. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00838 · Cited by 445
Self-citationMucoadhesive nanoparticulate systems for peptide drug delivery.
Takéuchi, Hirofumi, Yamamoto, Y., Hiromitsu, Kawashima, & Yoshiaki (2002) · 岐阜藥科大學紀要 = The annual proceedings of Gifu College of Pharmacy · Cited by 432
Rosenstock, J., Allison, D., Birkenfeld, A. L., Blicher, T. M., Deenadayalan, S., Jacobsen, J. B., Serusclat, P., Violante, R., Watada, H., Davies, M., et al. (2019) · JAMA · doi:10.1001/jama.2019.2942 · Cited by 421
Constraining Cyclic Peptides To Mimic Protein Structure Motifs
Hill, T. A., Shepherd, N. E., Diness, F., & Fairlie, D. P. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201401058 · Cited by 418
Self-citationRezai, T., Bock, J. E., Zhou, M. V., Kalyanaraman, C., Lokey, R. S., & Jacobson, M. P. (2006) · Journal of the American Chemical Society · doi:10.1021/ja063076p · Cited by 416
Penetration and enzymatic barriers to peptide and protein absorption
Lee, V. H. L., & Yamamoto, A. (1989) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(89)90018-5 · Cited by 413
Proteases Universally Recognize Beta Strands In Their Active Sites
Tyndall, J. D. A., Nall, T., & Fairlie, D. P. (2005) · Chemical Reviews · doi:10.1021/cr040669e · Cited by 412
Self-citationTransepithelial Transport of Fc-Targeted Nanoparticles by the Neonatal Fc Receptor for Oral Delivery
Pridgen, E. M., Alexis, F., Kuo, T. T., Levy-Nissenbaum, E., Karnik, R., Blumberg, R. S., Langer, R., & Farokhzad, O. C. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3007049 · Cited by 405
Function, structure and therapeutic potential of complement C5a receptors
Monk, P. N., Scola, A., Madala, P., & Fairlie, D. P. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707332 · Cited by 404
Self-citationShan, W., Zhu, X., Liu, M., Li, L., Zhong, J., Sun, W., Zhang, Z., & Huang, Y. (2015) · ACS Nano · doi:10.1021/acsnano.5b00028 · Cited by 395
Damgé, C., Michel, C., Aprahamian, M., & Couvreur, P. (1988) · Diabetes · doi:10.2337/diab.37.2.246 · Cited by 390
On-resin N-methylation of cyclic peptides for discovery of orally bioavailable scaffolds
White, T. R., Renzelman, C. M., Rand, A. C., Rezai, T., McEwen, C. M., Gelev, V. M., Turner, R. A., Linington, R. G., Leung, S. S. F., Kalgutkar, A. S., et al. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.664 · Cited by 386
New Modalities for Challenging Targets in Drug Discovery
Valeur, E., Guéret, S. M., Adihou, H., Gopalakrishnan, R., Lemurell, M., Waldmann, H., Grossmann, T. N., & Plowright, A. T. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201611914 · Cited by 382
Cell penetrating peptides: A concise review with emphasis on biomedical applications
Derakhshankhah, H., & Jafari, S. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.09.097 · Cited by 379
Beyond the Rule of 5: Lessons Learned from AbbVie’s Drugs and Compound Collection: Miniperspective
DeGoey, D. A., Chen, H.-J., Cox, P. B., & Wendt, M. D. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00717 · Cited by 378
Ionic liquids for oral insulin delivery
Banerjee, A., Ibsen, K., Brown, T., Chen, R., Agatemor, C., & Mitragotri, S. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1722338115 · Cited by 378
Improving Oral Bioavailability of Peptides by Multiple N‐Methylation: Somatostatin Analogues
Biron, E., Chatterjee, J., Ovadia, O., Langenegger, D., Brueggen, J., Hoyer, D., Schmid, H. A., Jelinek, R., Gilon, C., Hoffman, A., et al. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200705797 · Cited by 374
Mapping protein binding sites on the biomolecular corona of nanoparticles
Kelly, P. M., Åberg, C., Polo, E., O'Connell, A., Cookman, J., Fallon, J., Krpetić, Ž., & Dawson, K. A. (2015) · Nature Nanotechnology · doi:10.1038/nnano.2015.47 · Cited by 360
Mosenzon, O., Blicher, T. M., Rosenlund, S., Eriksson, J. W., Heller, S., Hels, O. H., Pratley, R., Sathyapalan, T., Desouza, C., Abramof, R., et al. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30192-5 · Cited by 351
Peptide conformations. Part 31. The conformation of cyclosporin a in the crystal and in solution
Loosli, H., Kessler, H., Oschkinat, H., Weber, H., Petcher, T. J., & Widmer, A. (1985) · Helvetica Chimica Acta · doi:10.1002/hlca.19850680319 · Cited by 347
Maisel, K., Ensign, L., Reddy, M., Cone, R., & Hanes, J. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.10.026 · Cited by 319
Targeting DnaN for tuberculosis therapy using novel griselimycins
Kling, A., Lukat, P., Almeida, D. V., Bauer, A., Fontaine, E., Sordello, S., Zaburannyi, N., Herrmann, J., Wenzel, S. C., König, C., et al. (2015) · Science · doi:10.1126/science.aaa4690 · Cited by 316
The Engineering of an Orally Active Conotoxin for the Treatment of Neuropathic Pain
Clark, R. J., Jensen, J., Nevin, S. T., Callaghan, B. P., Adams, D. J., & Craik, D. J. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.201000620 · Cited by 313
Choonara, B. F., Choonara, Y. E., Kumar, P., Bijukumar, D., du Toit, L. C., & Pillay, V. (2014) · Biotechnology Advances · doi:10.1016/j.biotechadv.2014.07.006 · Cited by 311
Yu, A. S. L., Cheng, M. H., Angelow, S., Günzel, D., Kanzawa, S. A., Schneeberger, E. E., Fromm, M., & Coalson, R. D. (2009) · The Journal of General Physiology · doi:10.1085/jgp.200810154 · Cited by 310
A luminal unfolding microneedle injector for oral delivery of macromolecules
Abramson, A., Caffarel-Salvador, E., Soares, V., Minahan, D., Tian, R. Y., Lu, X., Dellal, D., Gao, Y., Kim, S., Wainer, J., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0598-9 · Cited by 304
Glycopeptide antibiotics: Back to the future
Butler, M. S., Hansford, K. A., Blaskovich, M. A. T., Halai, R., & Cooper, M. A. (2014) · The Journal of Antibiotics · doi:10.1038/ja.2014.111 · Cited by 303
Jin, Y., Song, Y., Zhu, X., Zhou, D., Chen, C., Zhang, Z., & Huang, Y. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2011.10.075 · Cited by 301
Zinman, B., Aroda, V. R., Buse, J. B., Cariou, B., Harris, S. B., Hoff, S. T., Pedersen, K. B., Tarp-Johansen, M. J., Araki, E., PIONEER 8 Investigators, et al. (2019) · Diabetes Care · doi:10.2337/dc19-0898 · Cited by 300
Aguirre, T. A. S., Teijeiro-Osorio, D., Rosa, M., Coulter, I. S., Alonso, M. J., & Brayden, D. J. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.02.004 · Cited by 299
Self-citationDiscovery and Mechanism of Highly Efficient Cyclic Cell-Penetrating Peptides
Qian, Z., Martyna, A., Hard, R. L., Wang, J., Appiah-Kubi, G., Coss, C., Phelps, M. A., Rossman, J. S., & Pei, D. (2016) · Biochemistry · doi:10.1021/acs.biochem.6b00226 · Cited by 296
Anionic nanoparticles enable the oral delivery of proteins by enhancing intestinal permeability
Lamson, N. G., Berger, A., Fein, K. C., & Whitehead, K. A. (2019) · Nature Biomedical Engineering · doi:10.1038/s41551-019-0465-5 · Cited by 296
Romidepsin: a new therapy for cutaneous T-cell lymphoma and a potential therapy for solid tumors
Grant, C., Rahman, F., Piekarz, R., Peer, C., Frye, R., Robey, R. W., Gardner, E. R., Figg, W. D., & Bates, S. E. (2010) · Expert Review of Anticancer Therapy · doi:10.1586/era.10.88 · Cited by 291
Pieber, T. R., Bode, B., Mertens, A., Cho, Y. M., Christiansen, E., Hertz, C. L., Wallenstein, S. O. R., Buse, J. B., Akın, S., Aladağ, N., et al. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30194-9 · Cited by 287
Ortega, M. A., & van der Donk, W. A. (2016) · Cell Chemical Biology · doi:10.1016/j.chembiol.2015.11.012 · Cited by 287
Nano- and microparticles for the delivery of polypeptides and proteins
Couvreur, P., & Puisieux, F. (1993) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(93)90046-7 · Cited by 281
Hydrophobic ion pairing: encapsulating small molecules, peptides, and proteins into nanocarriers
Ristroph, K. D., & Prud'homme, R. K. (2019) · Nanoscale Advances · doi:10.1039/c9na00308h · Cited by 262
Effective oral delivery of insulin in animal models using vitamin B12-coated dextran nanoparticles
Chalasani, K. B., Russell-Jones, G. J., Jain, A. K., Diwan, P. V., & Jain, S. K. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.05.019 · Cited by 257
Low-Molecular-Weight Peptidic and Cyclic Antagonists of the Receptor for the Complement Factor C5a
Finch, A. M., Wong, A. K., Paczkowski, N. J., Wadi, S. K., Craik, D. J., Fairlie, D. P., & Taylor, S. M. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm9806594 · Cited by 246
Self-citationOral Delivery of Biologics for Precision Medicine
Durán‐Lobato, M., Niu, Z., & Alonso, M. J. (2020) · Advanced Materials · doi:10.1002/adma.201901935 · Cited by 246
Wang, J., Yadav, V., Smart, A. L., Tajiri, S., & Basit, A. W. (2015) · Molecular Pharmaceutics · doi:10.1021/mp500809f · Cited by 245
Twarog, C., Fattah, S., Heade, J., Maher, S., Fattal, E., & Brayden, D. J. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11020078 · Cited by 236
Self-citationSafety and efficacy of sodium caprate in promoting oral drug absorption: from in vitro to the clinic
Maher, S., Leonard, T. W., Jacobsen, J., & Brayden, D. J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.09.006 · Cited by 227
Self-citationAnderberg, E. K., Lindmark, T., & Artursson, P. (1993) · Pharmaceutical Research · doi:10.1023/a:1018909210879 · Cited by 221
X-ray structure of a decameric cyclophilin-cyclosporin crystal complex
Pflügl, G., Kallen, J., Schirmer, T., Jansonius, J. N., Zurini, M. G. M., & Walkinshaw, M. D. (1993) · Nature · doi:10.1038/361091a0 · Cited by 216
Mullard, A. (2019) · Nature Reviews Drug Discovery · doi:10.1038/d41573-019-00014-x · Cited by 212
Husain, M., Bain, S. C., Jeppesen, O. K., Lingvay, I., Sørrig, R., Treppendahl, M. B., & Vilsbøll, T. (2020) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13955 · Cited by 209
Peroral administration of nanoparticles
Kreuter, J. (1991) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(91)90048-h · Cited by 207
Kuek, V., Yang, Z., Chim, S. M., Zhu, S., Xu, H., Chow, S. T., Tickner, J., Rosen, V., Erber, W., Li, X., et al. (2016) · Scientific Reports · doi:10.1038/srep37482 · Cited by 202
Biotinylated liposomes as potential carriers for the oral delivery of insulin
Zhang, X., Qi, J., Lu, Y., He, W., Li, X., & Wu, W. (2014) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2013.07.011 · Cited by 194
Noble, S., & Markham, A. (1995) · Drugs · doi:10.2165/00003495-199550050-00009 · Cited by 191
Hughes, B. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2813 · Cited by 191
Granhall, C., Donsmark, M., Blicher, T. M., Golor, G., Søndergaard, F. L., Thomsen, M., & Bækdal, T. A. (2019) · Clinical Pharmacokinetics · doi:10.1007/s40262-018-0728-4 · Cited by 190
Oral Nanoparticles Exhibit Specific High-Efficiency Intestinal Uptake and Lymphatic Transport
Kim, K. S., Suzuki, K., Cho, H., Youn, Y. S., & Bae, Y. H. (2018) · ACS Nano · doi:10.1021/acsnano.8b04315 · Cited by 187
Halberg, I. B., Lyby, K., Wassermann, K., Heise, T., Zijlstra, E., & Plum-Mörschel, L. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30372-3 · Cited by 178
SEDDS: A game changing approach for the oral administration of hydrophilic macromolecular drugs
Mahmood, A., & Bernkop-Schnürch, A. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.07.001 · Cited by 176
Human DNA-PK activates a STING-independent DNA sensing pathway
Burleigh, K., Maltbaek, J. H., Cambier, S., Green, R., Gale, M., James, R. C., & Stetson, D. B. (2020) · Science Immunology · doi:10.1126/sciimmunol.aba4219 · Cited by 175
Safety and Efficacy of Oral Octreotide in Acromegaly: Results of a Multicenter Phase III Trial
Melmed, S., Popovic, V., Bidlingmaier, M., Mercado, M., van der Lely, A. J., Biermasz, N., Bolanowski, M., Coculescu, M., Schopohl, J., Racz, K., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-4113 · Cited by 173
Wang, C. K., Northfield, S. E., Colless, B., Chaousis, S., Hamernig, I., Lohman, R.-J., Nielsen, D. S., Schroeder, C. I., Liras, S., Price, D. A., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1417611111 · Cited by 171
Self-citationKrug, S. M., Amasheh, M., Dittmann, I., Christoffel, I., Fromm, M., & Amasheh, S. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.09.051 · Cited by 164
Multifunctional oral delivery systems for enhanced bioavailability of therapeutic peptides/proteins
Han, Y., Gao, Z., Chen, L., Kang, L., Huang, W., Jin, M., Wang, Q., & Bae, Y. H. (2019) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.01.004 · Cited by 164
Vergunst, C. E., Gerlag, D. M., Dinant, H., Schulz, L., Vinkenoog, M., Smeets, T. J. M., Sanders, M. E., Reedquist, K. A., & Tak, P. P. (2007) · Rheumatology · doi:10.1093/rheumatology/kem222 · Cited by 163
Tuvia, S., Atsmon, J., Teichman, S. L., Katz, S., Salama, P., Pelled, D., Landau, I., Karmeli, I., Bidlingmaier, M., Strasburger, C. J., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1179 · Cited by 160
Semaglutide for type 2 diabetes mellitus: A systematic review and meta‐analysis
Andreadis, P., Karagiannis, T., Malandris, K., Avgerinos, I., Liakos, A., Manolopoulos, A., Bekiari, E., Matthews, D. R., & Τσάπας, Α. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13361 · Cited by 160
Oral Semaglutide: A Review of the First Oral Glucagon-Like Peptide 1 Receptor Agonist
Bucheit, J. D., Pamulapati, L. G., Carter, N., Malloy, K., Dixon, D. L., & Sisson, E. M. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0185 · Cited by 156
Strategies to overcome the polycation dilemma in drug delivery
Bernkop‐Schnürch, A. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.07.017 · Cited by 155
Giugliano, D., Maiorino, M. I., Bellastella, G., Longo, M., Chiodini, P., & Esposito, K. (2019) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13847 · Cited by 153
Verma, A., Sharma, S., Gupta, P. K., Singh, A. K., Teja, B. V., Dwivedi, P., Gupta, G. K., Trivedi, R., & Mishra, P. R. (2015) · Acta Biomaterialia · doi:10.1016/j.actbio.2015.12.017 · Cited by 153
Fairlie, D. P., Tyndall, J. D. A., Reid, R. C., Wong, A. K., Abbenante, G., Scanlon, M. J., March, D. R., Bergman, D. A., Chai, C. L. L., & Burkett, B. A. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990315t · Cited by 152
Self-citationXu, J., Khan, A. R., Fu, M., Wang, R., Ji, J., & Zhai, G. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.07.020 · Cited by 151
New treatments and therapeutic targets for IBS and other functional bowel disorders
Simrén, M., & Tack, J. F. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0034-5 · Cited by 150
Mullard, A. (2020) · Nature Reviews Drug Discovery · doi:10.1038/d41573-020-00001-7 · Cited by 150
Binkley, N., Bolognese, M., Sidorowicz-Bialynicka, A., Vally, T., Trout, R., Miller, C., Buben, C. E., Gilligan, J. P., Krause, D. S., & for the Oral Calcitonin in Postmenopausal Osteoporosis (ORACAL) Investigators (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1602 · Cited by 149
Improving on Nature: Making a Cyclic Heptapeptide Orally Bioavailable
Nielsen, D. S., Hoang, H. N., Lohman, R., Hill, T. A., Lucke, A. J., Craik, D. J., Edmonds, D. J., Griffith, D. A., Rotter, C. J., Ruggeri, R. B., et al. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201405364 · Cited by 147
Self-citationBockus, A. T., Lexa, K. W., Pye, C. R., Kalgutkar, A. S. S., Gardner, J. W., Hund, K. C. R., Hewitt, W. M., Schwochert, J. A., Glassey, E., Price, D. A., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00128 · Cited by 147
Karsdal, M. A., Byrjalsen, I., Alexandersen, P., Bihlet, A., Andersen, J. R., Riis, B. J., Bay-Jensen, A. C., & Christiansen, C. (2015) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2014.12.019 · Cited by 143
Orthosteric and allosteric action of the C5a receptor antagonists
Liu, H., Kim, H. R., Deepak, R. N. V. K., Wang, L., Chung, K. Y., Fan, H., Wei, Z., & Zhang, C. (2018) · Nature Structural & Molecular Biology · doi:10.1038/s41594-018-0067-z · Cited by 143
Mucus permeating carriers: formulation and characterization of highly densely charged nanoparticles
de Sousa, I. P., Steiner, C., Schmutzler, M., Wilcox, M. D., Veldhuis, G. J., Pearson, J. P., Huck, C. W., Salvenmoser, W., & Bernkop‐Schnürch, A. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.12.024 · Cited by 142
Tuvia, S., Pelled, D., Marom, K., Salama, P., Levin-Arama, M., Karmeli, I., Idelson, G. H., Landau, I., & Mamluk, R. (2014) · Pharmaceutical Research · doi:10.1007/s11095-014-1303-9 · Cited by 142
Fjellestad‐Paulsen, A., Höglund, P., Lundin, S., & Paulsen, O. (1993) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1993.tb00990.x · Cited by 138
Mullard, A. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.4 · Cited by 137
Bockus, A. T., Schwochert, J. A., Pye, C. R., Townsend, C. E., Sok, V., Bednarek, M. A., & Lokey, R. S. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00919 · Cited by 135
Enhancement of Colonic Drug Absorption by the Transcellular Permeation Route
Tomita, M., Hayashi, M., Horie, T., Ishizawa, T., & Awazu, S. (1988) · Pharmaceutical Research · doi:10.1023/a:1015992819290 · Cited by 133
Rand, A. C., Leung, S. S. F., Eng, H. F., Rotter, C. J., Sharma, R., Kalgutkar, A. S. S., Zhang, Y., Varma, M. V. S., Farley, K. A., Khunte, B., et al. (2012) · MedChemComm · doi:10.1039/c2md20203d · Cited by 132
McCartney, F., Jannin, V., Chevrier, S., Boulghobra, H., Hristov, D. R., Ritter, N., Miolane, C., Chavant, Y., Demarne, F., & Brayden, D. J. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.08.008 · Cited by 132
Self-citationTargeting polymerised liposome vaccine carriers to intestinal M cells
Clark, M. A., Blair, H. J., Liang, L., Brey, R. N., Brayden, D. J., & Hirst, B. H. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00258-4 · Cited by 130
Self-citationOral Delivery of Antisense Oligonucleotides in Man
Tillman, L., Geary, R. S., & Hardee, G. E. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21084 · Cited by 127
In vivo evaluation of an oral self-emulsifying drug delivery system (SEDDS) for exenatide
Menzel, C., Holzeisen, T., Laffleur, F., Zaichik, S., Abdulkarim, M., Gumbleton, M., & Bernkop‐Schnürch, A. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.03.018 · Cited by 125
Chen, G., Svirskis, D. M., Lu, W., Man, Y. M., Huang, Y., & Wen, J. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.03.013 · Cited by 124
Zhang, J., Zhu, X. D., Jin, Y., Shan, W., & Huang, Y. (2014) · Molecular Pharmaceutics · doi:10.1021/mp400685v · Cited by 123
Harder, A., Schmitt-Wrede, H.-P., Krücken, J., Marinovski, P., Wunderlich, F., Willson, J., Amliwala, K., Holden-Dye, L., & Walker, R. (2003) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(03)00219-x · Cited by 119
Discovery of LFF571: An Investigational Agent for Clostridium difficile Infection
LaMarche, M. J., Leeds, J. A., Amaral, A., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201685h · Cited by 116
Epithelial integrity, cell death and cell loss in mammalian small intestine.
Mayhew, T. M., Myklebust, R., Whybrow, A., & Jenkins, R. (1999) · PubMed · doi:10.14670/hh-14.257 · Cited by 114
Crystal Structures of Protein-Bound Cyclic Peptides
Malde, A. K., Hill, T. A., Iyer, A., & Fairlie, D. P. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00807 · Cited by 114
Self-citationProfile of alisporivir and its potential in the treatment of hepatitis C
Gallay, P. A., & Lin, L. (2013) · Drug Design Development and Therapy · doi:10.2147/dddt.s30946 · Cited by 106
Castelli, M., Friedman, K., Sherry, J. H., Brazzillo, K., Genoble, L., Bhargava, P., & Riley, M. G. I. (2011) · Clinical Therapeutics · doi:10.1016/j.clinthera.2011.03.003 · Cited by 97
Some biological issues in oral, controlled drug delivery
Gruber, P., Longer, M. A., & Robinson, J. R. (1987) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(87)90066-4 · Cited by 96
Eldor, R., Arbit, E., Corcos, A., & Kidron, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059524 · Cited by 94
Enhancement of Colonic Drug Absorption by the Paracellular Permeation Route
Tomita, M., Shiga, M., Hayashi, M., & Awazu, S. (1988) · Pharmaceutical Research · doi:10.1023/a:1015999309353 · Cited by 93
Oral cyclosporine A - the current picture of its liposomal and other delivery systems
Czogalla, A. (2008) · Cellular & Molecular Biology Letters · doi:10.2478/s11658-008-0041-6 · Cited by 92
The Case for Vancomycin as the Preferred Drug for Treatment ofClostridium difficileInfection
Bartlett, J. G. (2008) · Clinical Infectious Diseases · doi:10.1086/587654 · Cited by 91
PEG-PGA enveloped octaarginine-peptide nanocomplexes: An oral peptide delivery strategy
Niu, Z., Samaridou, E., Jaumain, E., Coëne, J., Ullio, G., Shrestha, N., Garcia, J., Durán‐Lobato, M., Tovar, S. A., Santander-Ortega, M. J., et al. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.03.004 · Cited by 90
Karsdal, M. A., Henriksen, K., Bay‐Jensen, A., Molloy, B., Arnold, M., John, M. R., Byrjalsen, I., Azria, M., Riis, B. J., Qvist, P., et al. (2010) · The Journal of Clinical Pharmacology · doi:10.1177/0091270010372625 · Cited by 88
Enzyme decorated drug carriers: Targeted swords to cleave and overcome the mucus barrier
Menzel, C., & Bernkop‐Schnürch, A. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.10.004 · Cited by 88
Rademaker-Lakhai, J. M., Horenblas, S., MEINHARDT, W., Stokvis, E., de Reijke, T. M., Jimeno, J. M., Lázaro, L. L., Lopez-Martin, J. A., Beijnen, J. H., & Schellens, J. H. M. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1534 · Cited by 87
Walsh, E. G., Adamczyk, B. E., Chalasani, K. B., Maher, S., O‘Toole, E. B., Fox, J. S., Leonard, T. W., & Brayden, D. J. (2011) · Therapeutic Delivery · doi:10.4155/tde.11.132 · Cited by 86
Self-citationWelling, S. H., Hubálek, F., Jacobsen, J. B., Brayden, D. J., Rahbek, U. L., & Buckley, S. T. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.12.017 · Cited by 86
Self-citationBrayden, D. J., Gleeson, J. P., & Walsh, E. G. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.10.008 · Cited by 85
Self-citationPathobiology of neutrophil–epithelial interactions
Brazil, J. C., & Parkos, C. A. (2016) · Immunological Reviews · doi:10.1111/imr.12446 · Cited by 84
Oral semaglutide in type 2 diabetes
Anderson, S. L., Beutel, T. R., & Trujillo, J. M. (2020) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2019.107520 · Cited by 83
The Properties of the Mucus Barrier, a Unique Gel–How Can Nanoparticles Cross It?
Pearson, J. P., Chater, P. I., & Wilcox, M. D. (2016) · Therapeutic Delivery · doi:10.4155/tde-2015-0002 · Cited by 82
Song, Y., Shi, Y., Zhang, L., Hu, H., Zhang, C., Yin, M., Chu, L., Yan, X., Zhao, M., Zhang, X., et al. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00809 · Cited by 82
Henriksen, K., Byrjalsen, I., Andersen, J. R., Bihlet, A. R., Russo, L. A., Alexandersen, P., Valter, I., Qvist, P., Lau, E., Riis, B. J., et al. (2016) · Bone · doi:10.1016/j.bone.2016.07.019 · Cited by 78
Some biological issues in oral, controlled drug delivery
Gruber, P., Longer, M. A., & Robinson, J. R. (1988) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(88)90022-1 · Cited by 75
Fouché, M., Schaefer, M., Berghausen, J., Desrayaud, S., Blatter, M., Piéchon, P., Dix, I., Garcia, A. M., & ROTH, H. ‐. (2016) · ChemMedChem · doi:10.1002/cmdc.201600082 · Cited by 74
Total Synthesis, Structure, and Oral Absorption of a Thiazole Cyclic Peptide, Sanguinamide A
Nielsen, D. S., Hoang, H. N., Lohman, R., Diness, F., & Fairlie, D. P. (2012) · Organic Letters · doi:10.1021/ol3027347 · Cited by 73
Self-citationPusztai, A. J. (1989) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(89)90011-2 · Cited by 73
Reddy, L. H., Urmann, M., Besenius, M., Ulrich, W., Haack, T., Brun, P., Alié, J., Illel, B., Hortala, L., Vogel, R., et al. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.02.011 · Cited by 72
Reformulating cyclosporine A (CsA): More than just a life cycle management strategy
Guada, M., Beloqui, A., Kumar, M. N. V. R., Véronique Préat, A., Dios-Viéitez, M. D. C., & Blanco‐Prieto, M. J. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.01.056 · Cited by 72
Discovery of Potent and Orally Bioavailable Macrocyclic Peptide–Peptoid Hybrid CXCR7 Modulators
Boehm, M., Beaumont, K. C., Jones, R., Kalgutkar, A. S. S., Zhang, L., Atkinson, K. A., Bai, G., Brown, J. A., Eng, H. F., Goetz, G. H., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01028 · Cited by 72
Rationalization of the Membrane Permeability Differences in a Series of Analogue Cyclic Decapeptides
Witek, J., Wang, S., Ries, B., Lingwood, R., Dounas, A., ROTH, H. ‐., Fouché, M., Blatter, M., Lemke, O., Keller, B. G., et al. (2018) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.8b00485 · Cited by 72
Martins, J. P., D'Auria, R., Liu, D., Fontana, F., Ferreira, M. P. A., Correia, A., Kemell, M., Moslova, K., Mäkilä, E. M., Salonen, J., et al. (2018) · Small · doi:10.1002/smll.201800462 · Cited by 71
Taverner, A., Dondi, R., Almansour, K., Laurent, F., Owens, S. E., Eggleston, I. M., Fotaki, N., & Mrsny, R. J. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.05.270 · Cited by 70
Self-citationNovel strategy for oral peptide delivery in incretin-based diabetes treatment
Xu, Y., Hul, M. V., Suriano, F., Véronique Préat, A., Cani, P. D., & Beloqui, A. (2019) · Gut · doi:10.1136/gutjnl-2019-319146 · Cited by 69
Arbit, E., Goldberg, M. F., Gómez-Orellana, I., & Majuru, S. (2006) · Thrombosis Journal · doi:10.1186/1477-9560-4-6 · Cited by 68
Martins, J. P., Liu, D., Fontana, F., Ferreira, M. P. A., Correia, A., Valentino, S., Kemell, M., Moslova, K., Mäkilä, E. M., Salonen, J., et al. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b20821 · Cited by 68
Anthelmintic cyclooctadepsipeptides: complex in structure and mode of action
Krücken, J., Harder, A., Jeschke, P., Holden-Dye, L. M., O'Connor, V. M., Welz, C., & von Samson‐Himmelstjerna, G. (2012) · Trends in Parasitology · doi:10.1016/j.pt.2012.06.005 · Cited by 66
Cyclic Penta- and Hexaleucine Peptides without N -Methylation Are Orally Absorbed
Hill, T. A., Lohman, R., Hoang, H. N., Nielsen, D. S., Scully, C. C. G., Kok, W. M., Liu, L., Lucke, A. J., Stoermer, M. J., Schroeder, C. I., et al. (2014) · ACS Medicinal Chemistry Letters · doi:10.1021/ml5002823 · Cited by 66
Self-citationAkkuş‐Dağdeviren, Z. B., Nazir, I., Jalil, A., Tribus, M., & Bernkop‐Schnürch, A. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b00355 · Cited by 66
Claudin-9 structures reveal mechanism for toxin-induced gut barrier breakdown
Vecchio, A. J., & Stroud, R. M. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1908929116 · Cited by 66
Flexibility versus Rigidity for Orally Bioavailable Cyclic Hexapeptides
Nielsen, D. S., Lohman, R., Hoang, H. N., Hill, T. A., Jones, A., Lucke, A. J., & Fairlie, D. P. (2015) · ChemBioChem · doi:10.1002/cbic.201500441 · Cited by 65
Self-citationZOT-derived peptide and chitosan functionalized nanocarrier for oral delivery of protein drug
Lee, J., Sahu, A., Choi, W. I., Lee, J. Y., & Tae, G. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.06.059 · Cited by 65
Uhl, P., Grundmann, C., Sauter, M., Storck, P., Tursch, A., Özbek, S., Leotta, K., Roth, R., Witzigmann, D., Kulkarni, J. A., et al. (2019) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2019.102132 · Cited by 65
The Cyclophilin Inhibitor SCY-635 Disrupts Hepatitis C Virus NS5A-Cyclophilin A Complexes
Hopkins, S., Bobardt, M. D., Chatterji, U., Garcia-Rivera, J. A., Lim, P. J., & Gallay, P. A. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00693-12 · Cited by 64
Nanoparticle Transport in Epithelial Cells: Pathway Switching Through Bioconjugation
Fowler, R., Vllasaliu, D., Fernández‐Trillo, F., Garnett, M. C., Alexander, C., Horsley, H. T., Smith, B., Whitcombe, I. W. A., Eaton, M., & Stolnik, S. (2013) · Small · doi:10.1002/smll.201202623 · Cited by 64
From concept to in vivo testing: Microcontainers for oral drug delivery
Mazzoni, C., Tentor, F., Strindberg, S., Nielsen, L. H., Keller, S. S., Alstrøm, T. S., Gundlach, C., Müllertz, A., Marizza, P., & Boisen, A. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.10.013 · Cited by 63
A Novel Strategy for a Drug Delivery System Using a Claudin Modulator
Kondoh, M., Takahashi, A., Fujii, M., Yagi, K., & Watanabe, Y. (2006) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.29.1783 · Cited by 62
Oral delivery of peptides: opportunities and issues for translation
Brayden, D. J., & Alonso, M. J. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.10.005 · Cited by 62
Self-citationUltrasound-Mediated Delivery of RNA to Colonic Mucosa of Live Mice
Schoellhammer, C. M., Lauwers, G. Y., Goettel, J. A., Oberli, M. A., Cleveland, C., Park, J. Y., Minahan, D. J., Chen, Y., Anderson, D. G., Jaklenec, A., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.01.002 · Cited by 62
Niu, Z., Tedesco, E., Benetti, F., Mabondzo, A. M., Montagner, I. M., Marigo, I., González-Touceda, D., Tovar, S. A., Diéguez, C., Santander-Ortega, M. J., et al. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.02.024 · Cited by 62
Rehmani, S., & Dixon, J. E. (2018) · Peptides · doi:10.1016/j.peptides.2017.12.014 · Cited by 60
Presas, E., McCartney, F., Sultan, E., Hunger, C., Nellen, S., Álvarez, C. V., Ulrich, W., Bazile, D., Brayden, D. J., & O’Driscoll, C. M. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.07.045 · Cited by 60
Self-citationYoon, B. K., Jackman, J. A., Kim, M. C., Sut, T. N., & Cho, N. (2017) · Langmuir · doi:10.1021/acs.langmuir.6b03944 · Cited by 58
Abramson, A., Halperin, F., Kim, J., & Traverso, G. (2019) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2019.04.022 · Cited by 57
McCartney, F., Rosa, M., & Brayden, D. J. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11110565 · Cited by 56
Self-citationSweeney, Z. K., Fu, J., & Wiedmann, B. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500223x · Cited by 55
Wang, X., Maher, S., & Brayden, D. J. (2010) · Therapeutic Delivery · doi:10.4155/tde.10.5 · Cited by 53
Self-citationChater, P. I., Wilcox, M. D., & Pearson, J. P. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.12.006 · Cited by 53
Hashim, M. A., Korupolu, R. V., Syed, B., Horlen, K., Beraki, S., Karamchedu, P., Dhalla, A. K., Ruffy, R., & Imran, M. (2019) · Pharmacology Research & Perspectives · doi:10.1002/prp2.522 · Cited by 53
Fernandez, S., Jannin, V., Chevrier, S., Chavant, Y., Demarne, F., & Carrière, F. (2013) · Pharmaceutical Research · doi:10.1007/s11095-013-1053-0 · Cited by 50
High efficiency intranasal drug delivery using Intravail® alkylsaccharide absorption enhancers
Maggio, E., & Pillion, D. J. (2012) · Drug Delivery and Translational Research · doi:10.1007/s13346-012-0069-z · Cited by 47
Depsipeptide (FR901228, NSC-630176) pharmacokinetics in the rat by LC/MS/MS
Chan, K. K., Bakhtiar, R., & Jiang, C. L. (1997) · Investigational New Drugs · doi:10.1023/a:1005847703624 · Cited by 44
Hashimoto, Y., Tachibana, K., Krug, S. M., Kunisawa, J., Fromm, M., & Kondoh, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20164016 · Cited by 44
Gradauer, K., Nishiumi, A., Unrinin, K., Higashino, H., Kataoka, M., Pedersen, B. L., Buckley, S. T., & Yamashita, S. (2015) · Molecular Pharmaceutics · doi:10.1021/mp500776a · Cited by 43
Trier, S., Linderoth, L., Bjerregaard, S., Andresen, T. L., & Rahbek, U. L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109939 · Cited by 43
Liu, J., Ulrich, W., Funke, M., Besenius, M., Saaby, L., Fanø, M., Mu, H., & Müllertz, A. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.02.014 · Cited by 42
Nuhoho, S., Gupta, J., Hansen, B. B., Fletcher-Louis, M., Dang‐Tan, T., & Paine, A. (2019) · Diabetes Therapy · doi:10.1007/s13300-019-00706-y · Cited by 42
Geho, W. B., Rosenberg, L. N., Schwartz, S. L., Lau, J. R., & Gana, T. J. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814524871 · Cited by 41
Protamine nanocapsules as carriers for oral peptide delivery
Thwala, L. N., Delgado, D., Leone, K., Marigo, I., Benetti, F., Chenlo, M., Álvarez, C. V., Tovar, S. A., Diéguez, C., Csaba, N., et al. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.10.022 · Cited by 41
Seow, V., Lim, J., Cotterell, A. J., Yau, M., Xu, W., Lohman, R., Kok, W. M., Stoermer, M. J., Sweet, M. J., Reid, R. C., et al. (2016) · Scientific Reports · doi:10.1038/srep24575 · Cited by 40
Self-citationSchumacher‐Klinger, A., Fanous, J., Merzbach, S., Weinmüller, M., Reichart, F., Räder, A. F. B., Gitlin‐Domagalska, A., Gilon, C., Kessler, H., & Hoffman, A. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00466 · Cited by 40
Kondoh, M., Takahashi, A., & Yagi, K. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.07.004 · Cited by 39
Binkley, N., Bone, H. G., Gilligan, J. P., & Krause, D. S. (2014) · Osteoporosis International · doi:10.1007/s00198-014-2796-0 · Cited by 38
Efficient Peroral Delivery of Insulin via Vitamin B12 Modified Trimethyl Chitosan Nanoparticles
Ke, Z., Guo, H., Zhu, X. D., Jin, Y., & Huang, Y. (2015) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j3j88q · Cited by 37
Long, L., Lai, M., Mao, X., Luo, J., Yuan, X. H., Zhang, L., Ke, Z., Yang, L., & Deng, D. Y. B. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s218944 · Cited by 37
Maggio, E., & Grasso, P. (2011) · Regulatory Peptides · doi:10.1016/j.regpep.2011.02.009 · Cited by 35
LeCluyse, E. L., Sutton, S. C., & Fix, J. A. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38218-2 · Cited by 35
Hristov, D. R., McCartney, F., Beirne, J., Mahon, E., Reid, S., Bhattacharjee, S., Pénarier, G., Ulrich, W., Bazile, D., & Brayden, D. J. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b16104 · Cited by 34
Self-citationBrayden, D. J., & Walsh, E. G. (2014) · The AAPS Journal · doi:10.1208/s12248-014-9634-3 · Cited by 33
Self-citationSubchronic Oral Toxicity of Salcaprozate Sodium (SNAC) in Sprague-Dawley and Wistar Rats
Riley, M. G. I., Castelli, M., & Paehler, E. A. (2009) · International Journal of Toxicology · doi:10.1177/1091581809337737 · Cited by 32
Dittmann, I., Amasheh, M., Krug, S. M., Markov, A. G., Fromm, M., & Amasheh, S. (2014) · Pharmaceutical Research · doi:10.1007/s11095-014-1350-2 · Cited by 32
Fouché, M., Schaefer, M., Blatter, M., Berghausen, J., Desrayaud, S., & ROTH, H. ‐. (2016) · ChemMedChem · doi:10.1002/cmdc.201600083 · Cited by 31
Khedkar, A., Lebovitz, H. E., Fleming, A., Cherrington, A. D., Jose, V. M., Athalye, S. N., & Vishweswaramurthy, A. (2018) · Clinical and Translational Science · doi:10.1111/cts.12609 · Cited by 31
Fu, J., Tjandra, M., Becker, C., Bednarczyk, D., Capparelli, M. P., Elling, R. A., Hanna, I. H., Fujimoto, R. A., Furegati, M., Karur, S., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500862r · Cited by 30
Peptide Therapeutics: it‘s All in the Delivery
GRANT, M. L., & Leone‐Bay, A. (2012) · Therapeutic Delivery · doi:10.4155/tde.12.79 · Cited by 30
Polymeric Nanocarrier Formulations of Biologics Using Inverse Flash NanoPrecipitation
Markwalter, C. E., Pagels, R. F., Hejazi, A. N., Gordon, A. G. R., Skowron, A., & Prud’homme, R. K. (2020) · The AAPS Journal · doi:10.1208/s12248-019-0405-z · Cited by 30
Danielsen, E. M., & Hansen, G. H. (2017) · Tissue Barriers · doi:10.1080/21688370.2017.1361900 · Cited by 29
Colonic absorption of salmon calcitonin using tetradecyl maltoside (TDM) as a permeation enhancer
Petersen, S. B., Nielsen, L. G., Rahbek, U. L., Guldbrandt, M., & Brayden, D. J. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.01.009 · Cited by 28
Self-citation
Cited by
Oral delivery of therapeutic peptides and proteins: Technology landscape of lipid-based nanocarriers
Haddadzadegan, S., Dorkoosh, F., & Bernkop-Schnürch, A. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114097 · Cited by 424
Advances in Oral Drug Delivery Systems: Challenges and Opportunities
Lou, J., Duan, H., Qin, Q., Teng, Z., Gan, F., Zhou, X., & Zhou, X. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020484 · Cited by 397
Aroda, V. R., Blonde, L., & Pratley, R. E. (2022) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-022-09735-8 · Cited by 135
Protease-Resistant Peptides for Targeting and Intracellular Delivery of Therapeutics
Lucana, M. C., Arruga, Y., Petrachi, E., Roig, A., Lucchi, R., & Oller-Salvia, B. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13122065 · Cited by 102
Pratt, E., Ma, X., Liu, R., Robins, D., Haupt, A., Coskun, T., Sloop, K. W., & Benson, C. (2023) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.15184 · Cited by 62
Metadata
- Authors
- Brayden, D. J., Hill, T. A., Fairlie, D. P., Maher, S., & Mrsny, R. J.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2020
- Volume
- 157
- Pages
- 2-36
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W3030007836
- Cited by
- 253
- References
- 231
- FWCI
- 5.00
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.